Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma

BACKGROUND: Despite the established oncological benefits of neoadjuvant chemotherapy for esophageal squamous cell cancer, not all cases demonstrate benefit. Hence, predicting the response to chemotherapy before treatment is desirable. Some reports have shown that immune factors are related to the ch...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:World J Surg Oncol
Autori principali: Nakaya, Seiichi, Ogawa, Ryo, Hayakawa, Shunsuke, Fujihata, Shiro, Okubo, Tomotaka, Sagawa, Hiroyuki, Tanaka, Tatsuya, Takahashi, Hiroki, Matsuo, Yoichi, Takiguchi, Shuji
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2021
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8290605/
https://ncbi.nlm.nih.gov/pubmed/34281546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-021-02290-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi